clinical trial · NCT04511845
A Dose-Escalation Study of SPYK04 in Patients With Locally Advanced or Metastatic Solid Tumors (With Expansion).
Locally Advanced or Metastatic Solid TumorsSPYK04
brief summary
Phase I, open-label, multi-center study
started
Sep 10, 2020
primary completion
Jun 18, 2026
completion
Jun 18, 2026
last updated
Jul 30, 2026
official title
A Phase I, Open-Label, Multicenter, Dose Escalation and Cohort Expansion Study of SPYK04 as Monotherapy in Patients With Locally Advanced or Metastatic Solid Tumors
sourced from ClinicalTrials.gov · pharmadog mirrors structured fields, not the full protocol